The University of Helsinki – among the best in the world
Founded in 1640, the University of Helsinki is one of the best multidisciplinary research universities in the world. The University of Helsinki is an international academic community of 40,000 students and staff members. It operates on four campuses in Helsinki and at 15 other locations. The high-quality research carried out by the university creates new knowledge for educating diverse specialists in various fields, and for utilisation in social decision-making and the business sector.

The Institute for Molecular Medicine Finland (FIMM) is an international research institute focusing on human genomics and personalised medicine at the Helsinki Institute of Life Science (HiLIFE) of the University of Helsinki.

FIMM and Bayer are currently seeking outstanding candidates for the position of

FIMM-Bayer Joint Postdoctoral Researcher

Description: The Institute for Molecular Medicine (FIMM) and Bayer are seeking a joint postdoctoral researcher who has interest in anticancer drug development, and experience in cell and molecular or computational biology, or other related areas. The successful candidate will gain a rich and varied insight into drug development processes through exposure to both biomedical research at FIMM and clinical trials management at Bayer.

FIMM is an international research institute focusing on human genomics and personalized medicine at the Helsinki Institute of Life Science (HiLIFE) of the University of Helsinki. FIMM integrates molecular medicine research and technology and biobanking infrastructures under one roof, promoting translational research in grand challenge projects, specifically, the impact of genome information in personalized health and medicine, individualized cancer medicine, and novel imaging-based biomedicine.
Bayer is a global enterprise with core competencies in the fields of health care and agriculture. As an innovation company, it sets trends in research-intensive areas. Bayer’s products and services are designed to benefit people and improve their quality of life. Finland is a base for global pharmaceutical production, research & development and worldwide clinical trials.

Both FIMM and Bayer are keen to promote industry-academia partnerships and currently have ongoing collaborative research projects in cancer therapeutics. Entrepreneurial collaboration, building a bridge between new partners in academia and industry to address common scientific goals through sharing skills and expertise, provides a new community approach to both science and careers.

Within FIMM, the successful candidate will have the chance to work within either the Computational Systems Medicine Group ( led by Tero Aittokallio or the Translational Research and Personalized Medicine Group ( led by Caroline Heckman, depending on their interest and background. The project at FIMM aims to disseminate results in the form of scientific publications.

Within Bayer, the successful candidate will work as a support Study Manager and will become familiar with clinical research and drug development processes covering Phase I to Phase III trials. Eventually, the researcher will take over Study Management tasks.

Research training: At FIMM, the postdoctoral researcher will take part in the FIMMPOD Postdoctoral Professional Development Programme ( At Bayer, they will take part in the existing training programmes, e.g. in drug development processes.

Qualification and experience: A successful candidate holds a doctoral degree in cell and molecular or computational biology, or other related field, has experience in oncology research and has a solid publication track record.

To join the Computational Systems Biology group at FIMM, the candidate must have strong computational and analytical skills, and an interest in applying computational and systems biology approaches for analysing and modelling of large-scale drug testing together with molecular and clinical datasets. To join the Translational Research and Personalized Medicine group at FIMM, the candidate must be highly motivated to develop methods using molecular, functional and clinical data from hematology-oncology patients to help predict patient outcome, identify novel prognostic biomarkers, facilitate drug repositioning and drug development, and determine optimal combination treatment strategies.

The candidate should be fluent in English and have good scientific writing, communication and collaboration skills, the ability and flexibility to work in a global environment, and ability to work efficiently and independently also under tight timelines.

Salary and contract: A two year contract is available for the position, the starting date to be mutually decided. The salary will be commensurate with qualifications based on the Finnish university salary (YPJ) system depending on the credentials, previous experience and performance of the postdoctoral researcher.

The researcher is to be employed by FIMM and will work both at FIMM and Bayer on a weekly basis as separately agreed. The working time shall be balanced between FIMM and Bayer 50/50 on average on a monthly basis.

How to apply: The application deadline is 25.6.2018 at 23.59 EET. Applications are submitted by completing the application form and submitting a CV and a cover letter as a single PDF file (max 5 pages) in English through the University of Helsinki electronic recruitment system by clicking on Apply for job. Internal applicants (i.e., current employees of the University of Helsinki) must submit their applications through the SAP HR portal.

Review of applications will begin after the close of the call and applicants will be notified of the results of the preliminary review by 3.7.2018.

For further information about the position, please visit our websites at and or contact Tero Aittokallio (tero.aittokallio(at), Caroline Heckman (caroline.heckman(at) or Tarja Jalava (tarja.jalava(at) For questions about the FIMMPOD programme, please contact the FIMMPOD coordinator Heidi Virtanen (heidi.virtanen(at)

Useful links:
FIMM Research
University of Helsinki Research
The International Staff Office

Haku päättyy

25.06.2018 23:59 EEST